arrow
P

Patrick Mallon

University College Dublin
H指数:51
被引数:8,636

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterizing Host Inflammatory Bioprofiles in People With Postacute Sequelae SARS-CoV-2 Infection (PASC)

表征SARS-CoV-2感染后急性期后遗症(PASC)人群宿主炎症生物特征

2026-09-300
OAAI
Total plasma N-glycomic patterns of COVID-19 disease

新型冠状病毒肺炎疾病的总血浆N-糖型模式

2026-01-200
OAAI
Protocol for a core outcome set for pharmacological treatments in hospitalised patients with acute viral respiratory infections (COSAVRI)

急性病毒性呼吸道感染住院患者药物治疗核心结局指标集(COSAVRI)方案

2025-09-090
OAAI
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic Vaccination

抗体反应在 Mpox 感染后2年得以维持,但在 Modified Vaccinia Ankara-Bavarian Nordic 疫苗接种后并未出现。

2025-09-010
OAAI
People living with HIV on modern antiretrovirals do not display a pro-atherogenic lipid profile and have similar body composition compared to healthy controls

接受现代抗逆转录病毒治疗的HIV感染者不表现出促动脉粥样硬化性脂质谱,且与健康对照者具有相似的体成分。

2025-09-010
OAAI
Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

循环抗体滴度的特定阈值可预测SARS-CoV-2密切接触者的感染风险及疾病严重程度降低。

2025-05-220
OA
Associations between type III interferons, obesity and clinical severity of COVID-19

III型干扰素、肥胖与COVID-19临床严重程度之间的关系

2025-04-220
OA
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection

SARS-CoV-2疫苗后强大而持久的b细胞反应决定了对SARS-CoV-2感染的保护

2024-09-171
OAAI